Voyager Therapeutics (VYGR) Tops Q1 EPS by 287c

Voyager Therapeutics (NASDAQ: VYGR) reported Q1 EPS of $2.94, $2.87 better than the analyst estimate of $0.07. Revenue for the quarter came in at $150.48 million versus the consensus estimate of $10.04 million.

For earnings history and earnings-related data on Voyager Therapeutics (VYGR) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
• BW LPG Limited (BWLP) Reports Q1 EPS of $0.79